-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Hold on ANI Pharmaceuticals, Lowers Price Target to $90

Benzinga·08/10/2026 12:27:47
Listen to the news
Canaccord Genuity analyst Gary Nachman maintains ANI Pharmaceuticals (NASDAQ:ANIP) with a Hold and lowers the price target from $91 to $90.